Michael Karb

I am very thrilled to announce that we have recently participated in follow-on rounds of existing portfolio companies as well as backed two new exciting digital health companies: Doccla is the leading remote patient monitoring provider in Europe led by Dag Larsson and Martin Ratz. In their recent round led by Lakestar, and supported by Elaia and Optum Ventures we are excited to keep supporting their journey alongside General Catalyst, Giant Ventures, Speedinvest deepc, an orchestration platform for AI, starting with Radiology as the first vertical and led by Dr. Franz MJ Pfister, MD, MBA, where we followed-on alongside Sofinnova Partners with participation from new strategic investors KHP Ventures and SwissHealth Ventures who are supporting the market expansion Guardoc Health led by Hadassah Backman develops a compliance integrity platform to support understaffed and heavily overworked nursing staff with daily documentation, ensure compliance with regulations and improve the audit and billing process in care homes. We seeded the company together with our friends Pitango and the US investor Springbank among others Pi Health led by Geoffrey Kim and Bobby Reddy, MD has built an unique end-to-end software stack for clinical trials. Pi Health was recently spun out of BeiGene, and we invested in their series A together with AlleyCorp and Obvious Ventures    These investments take our Bertelsmann Investments Next growth program to yet another level.   We’re proud to backing the exceptional founders and their teams. We are fully convinced that these companies do make an important contribution to improving healthcare.   cc: Thorsten Wirkes Tim Schneider Agnes Eva Uhr, LL.M. Maximilian Boner #BertelsmannNext #VentureCapital #DigitalHealth #Growth #HealthcareInvestments https://lnkd.in/eDm4JXAh

302

8 Kommentare

KfW-Report: Health-Start-ups erhalten besonders viel Kapital https://buff.ly/4e3ptl1 Health start-ups are receiving substantial funding, according to a KfW report, highlighting their growing appeal to investors. This trend underscores the sector's potential for innovation and societal impact. As the demand for advanced healthcare solutions rises, investors are increasingly drawn to the promising prospects these start-ups offer. The report suggests that this influx of capital is crucial for fostering new technologies and improving healthcare delivery. #HealthStartups #InnovationInHealthcare

1

Turning a great idea into a market-ready product in healthcare is incredibly challenging.   This is why at VentureBlick we're all about giving healthcare startups the practical support they need to turn those ideas into solutions that really make a difference.   Through the Super Innovator Search competition, and with the incredible support of our partners, JLK Technology and Kalms Consulting, we're helping startups navigate the complex path to commercialisation, bringing them closer to their global goals.   Whether it’s strategic advice, validating tech or connecting innovators to the right people, we’re here to help innovators bring their visions to life.   Swipe left to check out how JLK Technology and Kalms Consulting are making this happen.   Just one week left to apply for the Super Innovator Search: 👉 https://lnkd.in/gEddQ6P7 #HealthcareInnovation #StartupSupport #SuperInnovatorSearch #Commercialisation #InnovationPartners

30

1 Kommentar

Stay tuned for our upcoming panel at the Health.Tech Conference in Munich 4:35pm tomorrow! We'll dive deep into the world of venture debt with a team of seasoned experts with the lenses of entrepreneurs, investors and venture debt lenders. Join us as we unravel the complexities of this financing tool and explore how it could be the key to unlocking your next growth strategy. Our panelists include: Christian Köhler, Chris Church, Daniel Mallon, George van Dorp, Humphrey Nokes See you tomorrow! #HealthTech #VentureDebt #GrowthStrategy #FinancePanel #healthtech

55

5 Kommentare

Boris Rhein in SAT1: Hessen soll Leitstandort für laserbasierte Kernfusion werden https://buff.ly/3y1FAAQ Boris Rhein discussed on SAT1 the potential for Hessen to become a leading location for laser-based nuclear fusion. This initiative aims to position Hessen as a hub for cutting-edge fusion technology, which could revolutionize the energy sector. By investing in research and infrastructure, Hessen has the opportunity to drive innovation and attract top talent in the field. This move aligns with the global shift towards sustainable energy sources and could pave the way for significant advancements in nuclear fusion technology. #Hessen #NuclearFusion #focusedEnergy

1

I had a blast at health.tech conference together my dear colleague Robert Huber representing Digital Dental & Healthcare Technology GmbH & Co. KG. We are building innovative dental medical devices and wanted to identify key partners, industry stakeholders, and hot trends in this sector. For me it was a success. Thanks to everyone we met. Here are three fast take-aways: #hardware is becoming more and more of a hot topic. Who would have thought? #fundraising from VCs is tough right now but there are other options of financing like getting public grants or even starting an equity crowdfunding campaign - a hot trend in the US right now. #startup life is like deep sea diving. You get the oxygen tank (cash) you dive in and from then on the clock starts ticking (burn rate) and you know you'll need to resurface (raise again/survive on your own) in the near future. Special thanks to Robert, it was a great event with you. Let's keep innovating. #medical #device #startup

34

4 Kommentare

It is only the first edition, but HLTH Europe has already established itself as the leading #HealthTech conference in Europe. Besides my 4 highlights, I also had the chance to moderate a panel on the topic "Last mile: Localising access for underserved areas" with 3 fantastic panelists: · Prathibha (President, Mayo Clinic Health System) · Minal (National Director of Primary Care and Community Transformation, NHS England) · Harmony (SVP, Chief Medical Officer & Head of Global Medical at ViiV Healthcare) PS: Amira (SVP Innovation at Siemens Healthineers): we missed you! Here are the key insights of the panel: Bringing healthcare #access to all, especially to underserved areas, has been a challenge since the inception of healthcare. With all the technology of our modern world, is #Healthcare access on the verge of being solved? The short answer is no. But there is hope. In the UK: ➝ There is a 15-year life expectancy gap between deprived areas, and wealthier neighbourhoods nearby. ➝ Funding struggles to keep up: In the next 15 years, a 37% increase in "ill-health costs" is expected, while the working population will increase by 4% over the same period. ➝ Increasing productivity is essential to solve the problem: A 1% decrease in productivity costs 1.5 billion pounds. In the US: ➝ The zip code is (still) a better determinant of health than the genetic code. ➝ Enabling access to underserved areas can also be seen as an opportunity rather than a problem. Tech adoption will be faster due to higher unmet needs, accelerating innovation that can later benefit well-served areas. Debunking one myth: ➝ For HiV, there is now a better access and coverage in Africa than in certain parts of developed countries (US and Europe). Pockets of innovation: ➝ To unlock HCP capacity, the NHS has a national program to move towards a modern General Practice, moving away from "first come first serve" to a new model based on population health and segmentation: the right care for the right person in the right way. First results show that 30% of GP appointments could be done via "messaging only" (instead of F2F visits), bringing massive efficiency gains. ➝ Mayo Clinic already has 75 specialties that are technology enabled, bringing the “Mayo medical care" in the rural areas via virtual and hybrid models, and also embedding the 50+ AI algorithms already active at Mayo. ➝ But increasing access is not only about Tech. Sometimes, it is about boldness: Viiv Healthcare, a pharma company specialised in HiV, gave the patent of its drugs away in 90+ underserved markets, enabling cheap and at-scale production. What does the future hold? Will someone living in an underserved area be able to visit the "Mayo Clinic in the metaverse with his / her digital twin?" Special thanks to Katy, Lina and Henry for this fantastic conference!

304

16 Kommentare

🤔 𝗜𝘀 𝗶𝗻𝘃𝗲𝘀𝘁𝗶𝗻𝗴 𝗶𝗻𝘁𝗼 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝘄𝗼𝗿𝘁𝗵 𝘁𝗵𝗲 𝗿𝗶𝘀𝗸? 🧬💊💉👩‍⚕️🧪🩻 This has been our topic at today‘s panel discussion at the invest.austria conference 2024. Together with my co-panelists Sophie Ehrlich (from EIT Health), Christian Bouda (from bloomblisser.com) and our moderator Markus Wanko (from xista) we‘ve been elaborating on: ✅ The various healthcare verticals and respective risk profiles ✅ Public vs. Private Funding and the need for a closer collaboration between these two ✅ Brining start-ups and SMEs closer to each other to accelerate innovation ✅ Current PE and VC environment ✅ Healthcare deal activity and outlook going forward Conclusion on the initial question: 𝗬𝗲𝘀, 𝗶𝘁 𝗶𝘀 𝗿𝗶𝘀𝗸𝘆 𝗮𝗻𝗱 𝘆𝗲𝘀, 𝗶𝘁 𝗶𝘀 𝘄𝗼𝗿𝘁𝗵 𝘁𝗵𝗲 𝗿𝗶𝘀𝗸! 𝗪𝗵𝘆 𝗶𝘀 𝗶𝘁 𝘄𝗼𝗿𝘁𝗵?! 1️⃣ „𝗛𝗘𝗔𝗟𝗧𝗛 𝗜𝗦 𝗪𝗘𝗔𝗟𝗧𝗛“ - it is our „duty“ to allocate capital and to invest into our own health through supporting innovation and the relevant infrastructure 2️⃣ Healthcare investing is „𝗛𝗔𝗥𝗗 𝗦𝗖𝗜𝗘𝗡𝗖𝗘“ driven investing -> less emotions, more facts 3️⃣ Healthcare is only at the very beginning of it‘s innovative disruption and the convergence between disciplines (e.g. life sciences and (deep) tech) will turbocharge this upcoming disruption -> 𝗖𝗢𝗡𝗩𝗘𝗥𝗚𝗘𝗡𝗖𝗘 => 𝗗𝗜𝗦𝗥𝗨𝗣𝗧𝗜𝗢𝗡 Besides that, there have been great discussions and stimulating thoughts, mainly around the political environment and the „𝗗𝗔𝗖𝗛𝗙𝗢𝗡𝗗𝗦“ concept = TOPIC OF THE DAY And we also saw insightful discussions on the foodtech, space investing markets, discussions on the democratization of the investment industry and - since we‘re in #vienna - the CEE investment environment. Thanks Daniela Haunstein, Nikolaus "Niki" Futter, Arnaud Béasse for organizing. Fantastic event 👏 Ps.: the #privateequity asset class still remains a little underrepresented in Austria. 🇦🇹 Room to improve ↗️ PPs.: It‘s been a pleasure meeting and catching up with fantastic people like Bernadette Ules, Csanad Daniel, Niklas Pichler, Patrik Cesky, Rudolf Kinsky, Heinz Brasic, Floyd Plettenberg, Stephan Freudl, Florentina Spindler, Karl Lankmayr, Tim Lammar, Zuzana Jahodníková, Michael Hähnle, Christian Bacher, Günter Leonhartsberger, Johannes Cech, Marko Mitrovic … #healthcaredeals #mergersandacquisitions cc: VINC - Healthcare Advisory, ISP HEALTHCARE GmbH

66

2 Kommentare

🇩🇪 𝗛𝗼𝘄 𝘁𝗼 𝗦𝗼𝗹𝘃𝗲 𝗚𝗲𝗿𝗺𝗮𝗻𝘆’𝘀 𝗙𝗲𝗱𝗲𝗿𝗮𝗹 𝗕𝘂𝗱𝗴𝗲𝘁 𝗦𝘁𝗿𝘂𝗴𝗴𝗹𝗲? 💶   At first glance, it is striking that the total sum of Germany’s special funds (€ 969 billion) is 𝗮𝗹𝗺𝗼𝘀𝘁 𝘁𝘄𝗶𝗰𝗲 this year’s federal budget (€ 477 billion). Most of the special fund’s volume is loan-financed: In other words, 𝗱𝗲𝗯𝘁 (€ 780 billion) instead of equity (€ 89 billion).   𝗖𝗗𝗨/𝗖𝗦𝗨 & 𝘁𝗵𝗲 𝗔𝗰𝘁𝘂𝗮𝗹 𝗢𝗿𝗶𝗴𝗶𝗻𝗮𝗹 𝗦𝗶𝗻   Although the traffic light coalition must face the political consequences of the excessive special funds use now, it was the CDU/CSU in the 1950s who committed the actual original sin. 21 of the currently still active 29 special funds (72%) have been passed by a CDU/CSU-led government. More than a third originates from the 𝗔𝗻𝗴𝗲𝗹𝗮 𝗠𝗲𝗿𝗸𝗲𝗹 𝗲𝗿𝗮.   𝗖𝗼𝗻𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗲𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗙𝗲𝗱𝗲𝗿𝗮𝗹 𝗖𝗼𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗼𝘂𝗿𝘁 𝗥𝘂𝗹𝗶𝗻𝗴   The improper use of not fully utilized funds from the COVID-19 pandemic prompted the CDU/CSU Fraktion to file a constitutional suit: With success. From November 15, 2023, the federal government attempts to close the fiscal gap resulting by the ruling of the Federal Constitutional Court. As of now, there are two options for the use of special funds left. The first option is to get a 𝘁𝘄𝗼-𝘁𝗵𝗶𝗿𝗱𝘀 𝗺𝗮𝗷𝗼𝗿𝗶𝘁𝘆 𝘃𝗼𝘁𝗲 in the Deutscher Bundestag, which has already worked with the 'Sondervermögen Bundeswehr'. The second option is to exclusively use the 𝘆𝗶𝗲𝗹𝗱𝘀 𝗼𝗻 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 from existing or new specials funds. As an example, the 'Sondervermögen Generationenkapital' can be mentioned here.   In a nutshell, the use of special funds has become much more challenging and makes other options more likely. Over the next few weeks, PIVOT Regulatory will continue analyzing several options on a case-by-case basis in terms of 𝗲𝗰𝗼𝗻𝗼𝗺𝗶𝗰 𝘃𝗶𝗮𝗯𝗶𝗹𝗶𝘁𝘆 and 𝗽𝗼𝗹𝗶𝘁𝗶𝗰𝗮𝗹 𝗳𝗲𝗮𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆 how Germany can adopt a compliant fiscal budget in 2025. Stay tuned!   #germany #fiscal #federalbudget #publicfinance #ministryoffinance #economics #politics #finance

20

Do you want to find out how our xista science ventures #portfolio company contextflow supports #radiologists in #cancer diagnostics using advanced #ai? Check out the article below ⬇️

12

🩷🤍 Reflecting back on last week’s health.tech conference in Munich, where I joined over 3,000 healthtech enthusiasts from across Europe. 🌟 My Top Highlights: 1. Panel Moderation: I had the honour of moderating a panel with Laura A. (Sherpa), Dr. Ron Lehnert (Caterna Vision GmbH), Jhonatan Bringas Dimitriades, MD (Lapsi Health), Carsten Laue (machineMD). They shared practical tips and real-world experiences on market entry. Two points that stuck with me the most: 👩‍⚕️ KOL Influence: Engaging Key Opinion Leaders (KOLs) during market entry can be a game-changer. One founder noted how a KOL opened doors for hundreds of millions of dollars in revenue, another mentioned how their startup became a networking hub for KOLs eager to collaborate. 💫 No “one size fits all”: The best approach to market entry depends on the product, target audience, market, and regulatory landscape. Strategy and flexibility are key! 2. Program Legacy: Seeing the DiGinnovation program of EIT Health thrive under Sergio González Álvarez's leadership was incredibly rewarding. I was grateful to be given an opportunity to design and launch this initiative with the team in my EIT Health days back in 2022. It's inspiring to witness this impactful work continue to grow in very good hands. The fourth edition of the program just opened for applications, if you are a later-stage digital health startup looking to obtain reimbursement in one of the EU countries, check it out (link in the comments). 3. Sustainable Innovations: The conference also highlighted eco-friendly practices with sustainable catering and merchandise. It is fantastic to see our industry taking steps towards sustainability. The event was a great opportunity to share the work of Vision Health Pioneers Incubator and connect our work with the wider ecosystem. Please reach out if you would like to continue the discussions about ways to collaborate. Susa Horvath Huge thanks to Joy Cürten, Laura Kuppelwieser, and Victoria Krönung for the invitation and stellar organisation. #HT24 📸 health.tech Conference

87

9 Kommentare

𝗘𝘅𝗰𝗶𝘁𝗲𝗱 𝘁𝗼 𝘀𝗵𝗮𝗿𝗲 𝟲 𝗸𝗲𝘆 𝗹𝗲𝘀𝘀𝗼𝗻𝘀 𝗹𝗲𝗮𝗿𝗻𝗲𝗱 📘 𝗳𝗿𝗼𝗺 𝗺𝘆 𝘁𝗶𝗺𝗲 𝗮𝘀 𝗖𝗘𝗢 𝗮𝘁 𝗡𝗲𝘄𝘀𝗲𝗻𝘀𝗲𝗹𝗮𝗯. The focus is on prescription digital therapeutics, data, and innovative business models. These insights come from experiences, navigating the unique challenges and opportunities within Germany's early DiGA landscape. 1️⃣ 𝘿𝙞𝙂𝘼 𝙄𝙣𝙣𝙤𝙫𝙖𝙩𝙞𝙤𝙣 & 𝙈𝙖𝙧𝙠𝙚𝙩 𝘿𝙮𝙣𝙖𝙢𝙞𝙘𝙨 💡 "𝘝𝘢𝘭𝘶𝘦 𝘤𝘳𝘦𝘢𝘵𝘪𝘰𝘯 𝘥𝘰𝘦𝘴 𝘯𝘰𝘵 𝘦𝘢𝘴𝘪𝘭𝘺 𝘢𝘭𝘪𝘨𝘯 𝘸𝘪𝘵𝘩 𝘷𝘢𝘭𝘶𝘦 𝘤𝘢𝘱𝘵𝘶𝘳𝘦." 2️⃣ 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗮𝗻𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝘆: 𝗗𝗿𝗶𝘃𝗶𝗻𝗴 𝗘𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 💡 "𝘗𝘳𝘰𝘷𝘪𝘥𝘦𝘳 𝘢𝘥𝘩𝘦𝘳𝘦𝘯𝘤𝘦 𝘤𝘰-𝘥𝘳𝘪𝘷𝘦𝘴 𝘳𝘦-𝘱𝘳𝘦𝘴𝘤𝘳𝘪𝘱𝘵𝘪𝘰𝘯 𝘴𝘶𝘤𝘤𝘦𝘴𝘴." 3️⃣ 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝗮𝗻𝗱 𝗗𝗮𝘁𝗮 𝗙𝗹𝗼𝘄 💡 “𝘋𝘪𝘨𝘪𝘵𝘢𝘭 𝘣𝘪𝘰𝘮𝘢𝘳𝘬𝘦𝘳 𝘤𝘳𝘦𝘢𝘵𝘦 𝘷𝘢𝘭𝘶𝘦 𝘣𝘦𝘺𝘰𝘯𝘥 𝘵𝘳𝘪𝘢𝘭𝘴." 4️⃣ 𝗗𝗿𝘂𝗴-𝗗𝗲𝘃𝗶𝗰𝗲 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗼𝗻 💡 "𝘉𝘦𝘺𝘰𝘯𝘥 𝘴𝘺𝘯𝘦𝘳𝘨𝘺: 𝘥𝘳𝘶𝘨 & 𝘥𝘦𝘷𝘪𝘤𝘦 𝘰𝘧𝘧𝘦𝘳𝘴 𝘮𝘢𝘯𝘺 𝘣𝘦𝘯𝘦𝘧𝘪𝘵𝘴.”  5️⃣ 𝗧𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗧𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 💡"𝘛𝘢𝘳𝘨𝘦𝘵𝘪𝘯𝘨 𝘵𝘩𝘦 𝘶𝘯𝘥𝘳𝘶𝘨𝘨𝘢𝘣𝘭𝘦 𝘳𝘦𝘲𝘶𝘪𝘳𝘦𝘴 𝘥𝘪𝘨𝘪𝘵𝘢𝘭 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯." 6️⃣ 𝗕𝗿𝗮𝗻𝗱𝗶𝗻𝗴 𝗮𝗻𝗱 𝗣𝗵𝗮𝗿𝗺𝗮 𝗖𝗼-𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 💡 "𝘛𝘩𝘦 𝘤𝘩𝘢𝘭𝘭𝘦𝘯𝘨𝘦: 𝘌𝘯𝘵𝘳𝘦𝘱𝘳𝘦𝘯𝘦𝘶𝘳𝘴𝘩𝘪𝘱 𝘷𝘴. 𝘐𝘯𝘵𝘳𝘢𝘱𝘳𝘦𝘯𝘦𝘶𝘳𝘴𝘩𝘪𝘱." In 2022, I had the opportunity to contribute these "Lessons Learned" to the Data Science in Healthcare seminar at Goethe Business School - Goethe University Frankfurt, where I provided a deep dive into the intersection of data-driven decision-making and healthcare innovation. Over the next posts, I’ll be breaking down these lessons for the broader digital health community. Stay tuned! #DTx #PDT #digitalhealth #DiGA #innovation #data #businessmodels #PDURS

27

1 Kommentar

🚨 Red Alert for Germany’s Startup Ecosystem: A 30% Drop in Active Investors – How Can We Keep the Innovation Engine Running? A recent article from Handelsblatt (link in comments) points out that early-stage startups are especially at risk during this downturn since they depend on venture capital to scale. The expanding funding gap will further stifle growth in areas where innovation is most needed. Yet, within this challenge lies opportunity: 🌱 Resilient Sectors Lead the Way Sectors like #GreenTech and #AI are still drawing investment, showing their potential to drive innovation. These industries highlight where Germany can have the most significant impact. 🏠 Family Offices as Growth Catalysts As traditional investors pull back, family offices can step up. By leveraging patient capital, they can empower promising startups and lay the foundation for long-term success. 🤝 Venture Clienting as a Key to Co-Innovation Strategic partnerships between startups and established businesses bridge the funding gap. These alliances not only drive digital transformation but also deliver mutual value and foster innovation. At D11Z. Ventures, we believe Germany’s competitive edge depends on collaboration. That's why we invest in high-potential startups and create co-innovation opportunities with family offices and industry leaders. Together, we're fostering an ecosystem that drives innovation and supports long-term growth. 🚀 💬 How can family offices and industry leaders support the next wave of startup innovation? Share your ideas below! #D11ZVentures #Innovation #StartupEcosystem #VentureCapital #InnovationLeadership #FamilyOffices #CoInnovation #ArtificialIntelligence

54

3 Kommentare

Thank you, Thomas Hagemeijer, for sharing these thought-provoking insights on the transformative role of virtual wards in healthcare. This model, pioneered by the NHS and now embraced by Asklepios in Germany, is a decisive step towards redefining patient care. Here’s why this matters: 1️⃣ Scaling Patient-Centered Care with Virtual Wards Virtual wards aren’t just about moving hospital beds to the home; they’re about creating a robust, scalable system for delivering hospital-quality care remotely. By combining real-time monitoring with centralized coordination, Asklepios sets a new standard that could transform healthcare delivery across Germany, making care more accessible and flexible for patients and providers. This potential impact on patient care is truly inspiring. 2️⃣ Adaptability: The Key to Success While virtual wards offer impressive cost savings and help alleviate staffing pressures, their effectiveness varies based on context—patient demographics, technology integration, and care team dynamics all play a role. This variation underscores the need for adaptable strategies. As healthcare professionals, we have the power to ensure that virtual wards effectively meet specific community and patient needs rather than relying on a one-size-fits-all approach. 3️⃣ Driving Innovation in a Time of Change Even amid financial reforms, Asklepios’s commitment to virtual wards exemplifies a bold vision for German healthcare. By involving payors early on, they’re paving the way for a supportive reimbursement structure that could accelerate adoption and make virtual care a sustainable part of the system. This move may be precisely what Germany needs to modernize healthcare delivery. Thank you for spotlighting the potential of virtual wards, Thomas. Your post highlights a powerful opportunity to adapt and advance our healthcare models to meet evolving patient expectations and system challenges. It also underscores the importance of continuous evaluation and improvement in the implementation of virtual wards, fostering a culture of learning and innovation in healthcare. #VirtualWards #HealthcareInnovation #DigitalHealth #PatientCenteredCare #HealthTech #HealthcareReform #Asklepios #NHS

3

1 Kommentar

🚀 A Conversation on Enabling Healthcare Innovation with Venture Capital: I recently had the privilege to welcome Nicole Graner from the Süddeutsche Zeitung at our YZR Capital headquarters. Article in 1st comment. Tldr: 🔎 Critical need for venture capital in fostering healthcare innovation. 🔎 How our expertise-driven approach is making a difference. 🔎 My journey as a physician, entrepreneur and investor, always deeply intertwined with my passion for #healthtech. 💡 That's why: alongside Markus Feuerecker I co-founded YZR Capital with a clear vision: to propel European healthtech startups into global leadership positions. 💡 We strongly believe that our team’s expertise in health is key to supporting founders who are dedicated to change the European healthtech ecosystem. ✔ Apparently our name is difficult to pronounce – for everyone who is still wondering, it’s “wise” with an R at the end ;) -> Thanks again to Nicole - it was a pleasure! And thanks to the fantastic team at YZR Capital - Christina Schmidt, Paul Epple, Urs Keller, Holger Ebersberger, Elmar Willebrand, Michael Dr. Bitzer. #HealthTech #VentureCapital #Innovation

73

5 Kommentare

https://lnkd.in/emRQNxz7 An insightful article by Winand von Petersdorff-Campen in FAZ discusses why America is outpacing Europe economically. The key takeaway: America's dynamic labor market and productivity gains have been vital for its quicker recovery. This reinforces our perspective in Real Estate Investment & Development, where we observe a disparate development favoring the American market due to significantly stronger demand drivers. This trend aligns with our strategic focus and bolsters our growth prospects in the U.S. By the end of last year, the U.S. had fully recovered from the pandemic, while the Eurozone's GDP was 5% below trend, the UK was 6% behind, and Canada was 4% behind. Alarmingly, growth trends in Europe and Canada have weakened, suggesting these economies may never fully recover from the pandemic's impact. Here are the main points: U.S. Economic Outperformance: America has recovered from the pandemic faster than most industrial nations, including Germany. Key Difference: Higher productivity and longer working hours by American workers. Federal Reserve Study Insights: o  Traditional factors like government spending explain differences only partially. o  U.S. avoided deep recession due to a dynamic labor market, unlike Europe which used measures like short-time work to keep unemployment low initially. o  Europe's rigid employment policies hindered adaptation to new economic conditions. o  U.S. saw a surge in new business formations post-pandemic, while Europe lagged. Central Bank Policies: Although central banks in the U.S. and Europe raised interest rates nearly simultaneously since 2022, the impact varied. In the U.S., higher rates didn't affect many citizens and businesses due to fixed-rate mortgages and loans, and a lower reliance on bank credit. In contrast, Canadians and Europeans felt the impact more, yet this still doesn't fully explain the growth gap. Policy Impacts: The Ukraine war and slow EU funding approval impacted Europe more severely.  

11

2 Kommentare

📢 Revamping DACH Healthcare with Roll-Up Strategies 📈 Private equity investors are reshaping the fragmented healthcare sector in the DACH region through strategic roll-up practices. By merging smaller entities like dental clinics and radiology centers, investors unlock synergies, streamline operations and enhance value. Winterberg Group AG highlights this trend emphasising centralised administrative functions and robust healthcare IT systems as key drivers of success. Fabian Kroeher states, “Standardising operations and implementing best practices not only reduces costs but also enhances patient outcomes significantly.” Key players like Castik Capital and Nordic Capital are leading the charge demonstrating the potential of this approach. With careful execution and a focus on integration the future of healthcare in the DACH region looks promising. Read more in our new article below 💡 #privateequty #healthcare #investment #DACH #innovation #strategy #winterberggroup

21

Many factors play a role when fundraising. How fast does ECB's interest rate decisions translate into market actions? #ecb #funding #fundingrounds #venturecapital #privateequity #publicfunding #markets #interestrate #policy #sentiment #investmentstrategies #rateprediction

3

Virtual wards present a potentially promising advancement in healthcare, but their success hinges on the true driving force behind their implementation. If the focus is on better patient outcomes, particularly for those who can safely receive care at home, the benefits are substantial. For instance, patients at home face a lower risk of hospital-acquired infections like MRSA. Additionally, virtual wards can be highly effective for managing chronic diseases, allowing for continuous remote monitoring and timely interventions without the need for frequent hospital visits. However, caution is necessary. If virtual wards are deployed primarily for cost management, the resulting patient experience (PX) will be inside-out, designed to meet the hospital’s needs rather than the patients’. To truly succeed, virtual wards must be designed with an outside-in approach, ensuring that patient needs and outcomes are at the forefront of the design and implementation process.

7